AGN another box ticked! spoke to a pharma science buddy who...

AGN another box ticked! spoke to a pharma science buddy who noted that it's very rare for pre-clinical bio drugs to demonstrate no negative reciprocal effects when testing on animals. Recent peer reviews also seem to show conviction in ARG-007, on top of this the market is not only a monopoly in terms of effectiveness and method and efficiency of administering, but it's a bloody big one!

Worth a study, I know this a DT forum but I've been following since IPO and it seems like a unicorn in the making

would love to hear someone else's perspective!

cheers